The treatment of periodontitis angular alveolar bone resorption with pure-phase β-tricalcium phosphate

Objective To evaluate the treatment effects of periodontitis alveolar bone resorption using pure-phase (3-tricalcium phosphate (Cerasorb) bone graft. Methods Twelve alveolar angular bone resorption sites from 5 perodontitis patients were selected. Clinical examinations including probing depth, attachment loss, bleeding index, and standardized reproducible periapical films were taken before the bone graft treatment. Examinations were also done at 3 months and 6 months after treatment. The data was analyzed by various statistical tests. Results After the bone graft treatment, probing depth, attachment loss, and bleeding index were all significantly improved at the 3 and 6 month examination marks compared to the baseline ( P = 0. 001). There were no statistical differences between 3 and 6 months in the clinical findings. The amount of alveolar bone was significantly increased in 6 months after the bone graft treatment ( P 0.05 ). Conclusion The treatment of periontontitis alveolar angular bone resorption with pure - phase (3 -tricalcium phosphate demonstrates a satisfactory clinical outcome.